Prescription drug costs are one of the most frustrating parts of the American healthcare system. A medication that costs pennies to manufacture can retail for hundreds of dollars at the pharmacy counter. Cost Plus Drugs — the online pharmacy launched by entrepreneur Mark Cuban — was built around a direct challenge to that system. Here's what it actually is, how it works, and what determines whether it could meaningfully lower your drug costs.
Cost Plus Drugs (officially Mark Cuban Cost Plus Drug Company) is an online pharmacy and drug manufacturer that operates on a transparent, markup-based pricing model. Rather than working within the traditional pharmaceutical supply chain — which involves manufacturers, wholesalers, pharmacy benefit managers (PBMs), and insurers — Cost Plus Drugs publishes a simple formula for what you pay:
The premise is straightforward: by cutting out intermediaries and publishing prices openly, the company aims to offer dramatically lower prices on many generic medications compared to what consumers pay at traditional retail pharmacies.
Traditional drug pricing is layered and opaque. A drug passes through multiple hands before reaching you, and each step adds cost. Pharmacy Benefit Managers (PBMs) — the largely invisible middlemen who negotiate between insurers and pharmacies — play a significant role in determining what you ultimately pay at the counter. Their incentives don't always align with lower consumer prices.
Cost Plus Drugs bypasses much of this by:
Because prices are published and the markup formula is disclosed, patients can see exactly where the cost comes from — a transparency that is genuinely unusual in pharmaceutical retail.
This is where individual circumstances start to matter significantly.
Cost Plus Drugs carries a formulary of generic medications — not brand-name drugs. If your prescription is for a brand-name medication with no generic equivalent, you likely won't find it there. The catalog covers a wide range of therapeutic categories, including:
However, the formulary is not exhaustive. Specialty drugs, biologics, newer brand-name medications, and many niche generics may not be available. Whether your specific medication is listed is the first thing you'd need to check.
The answer depends heavily on your personal situation. Several variables determine whether switching makes sense:
| Factor | What It Means for You |
|---|---|
| Insurance status | If you have no insurance or a high deductible, out-of-pocket prices matter more |
| Your current copay | If your insurer negotiates a very low copay, Cost Plus may not beat it |
| Whether your drug is generic | Brand-name drugs are largely not available |
| Your specific medication | Price differences vary widely by drug — some are dramatic, others minimal |
| Mail-order convenience | Medications are shipped to your home, which suits some patients and not others |
💡 People who often see the largest potential benefit include those who are uninsured, underinsured, on high-deductible health plans, or who take long-term generic medications where retail prices can be particularly inflated. For someone with robust insurance and low copays on their specific drugs, the math may work out differently.
This is a common point of confusion. Cost Plus Drugs is primarily a cash-pay pharmacy — you pay directly rather than running claims through your insurance. That means:
Whether bypassing insurance for a particular drug makes financial sense is a calculation that depends on your plan design, your deductible status at a given point in the year, and the specific price difference for your medication. This is genuinely a "run the numbers for your situation" question — there's no universal answer.
It's worth being clear-eyed about what this model doesn't solve:
The model is a meaningful innovation in a narrow but important space — affordable generics — rather than a wholesale fix for drug pricing broadly.
If you're curious whether Cost Plus Drugs could lower your costs, here's the landscape of what you'd want to assess:
The transparency of Cost Plus Drugs pricing — everything is listed publicly — makes this comparison genuinely doable in a way that traditional pharmacy pricing often doesn't allow.
Cost Plus Drugs represents a real structural challenge to the way drug pricing has traditionally worked in the U.S. By making the markup visible and predictable, it creates price pressure that has already prompted some established pharmacies and PBMs to respond with their own pricing initiatives.
Whether it saves you money specifically comes down to which drugs you take, what you currently pay, and how your insurance is structured. Those variables are yours to evaluate — but the information you need to do it is unusually accessible.
